SBOT - Stellar Biotechnologies misses by $0.03 misses on revenue February, 05 2019 04:31 PM Stellar Biotechnologies Inc. Stellar Biotechnologies (NASDAQ:SBOT): Q1 GAAP EPS of -$0.26 misses by $0.03. More news on: Stellar Biotechnologies Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...